All News

One of India's fastest growing CDMOs goes "beyond the norm" to reinvent itself as a new generation global CDMO.

The transaction will enable Sanofi to expand and accelerate development of BTK inhibitors across multiple indications, including MS and other central nervous system diseases.

The instrument also tests ethanol and isopropanol concentrations to confirm product efficacy.

The free webinar investigates online training and how it can essentially optimize the tablet manufacturing process.

Atomwise technology removes the barriers of physical screening that have limited the success of traditional methods for small molecule drug discovery.

Details of new CPHI South East Asia Online Business Matchmaking Platform to be announced shortly.

Plant 4 will add 256 KL capacity to its site, which is scheduled to commence manufacturing activities in the second half of 2022.

The company is also scaling up its manufacturing capability with its partners — Lonza, Catalent and Rovi — should the vaccine get the green light.

The company has reserved one fill/finish line for the next 18 months to guarantee the supply of vaccines required to fight COVID-19 in the UK.

The world’s largest in-person pharma exhibition CPHI Worldwide has transformed into a unique digital experience and expo for 2020 to ensure that the industry can continue to connect, interact and learn despite current restrictions due to the ongo...

Customers in the region will have the opportunity to conduct laboratory-scale compression and coating trials, using automated coating equipment.

The extension will add a capacity of over 10 million doses per annum to the site.

New mid-scale microbial facility will support Servier with API for acute lymphoblastic leukemia therapies.

SPI Pharma has announced an expansion of its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Mannogem XL Opal, Mannogem XL Ruby, Mannogem Emerald, and Mannogem Onyx. 

The company expects to manufacture the clinical-stage gene therapy product in its commercial-scale GMP manufacturing facilities.

Discussions relate to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system.

The companies are set to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021.

NTC Srl, R&D focused pharmaceutical company headquartered in Italy, has obtained CE certifications for three medical devices based on TIAB technology: a new vaginal gel GENIGEL, a proctological cream-gel TIAHEM and a powder for wound care TIAHEL.

Bendalis and Inceptua enter into an exclusive oncology medicine supply agreement for clinical trials

Novartis' generics and biosimilars division, Sandoz, has announced a joint investment with the Austrian federal government worth over EUR 150 million to boost integrated antibiotics manufacturing in Europe.

The facility will support the company'a goal of being climate, land and people positive by 2030.

The transaction will enable the CDMO to offer plasmid production and end-to-end cell and gene therapy services.

The European Medicines Agency's human medicines committee (CHMP) has recommended the suspension of European marketing authorizations of generic medicines tested by Panexcell Clinical Laboratories at its site in Mumbai, India, citing irregularities in h...

The company will adapt its digital platform to digitize any COVID-19 antibody rapid test assay and embed this within an app available on smartphones and tablets.

The event organizers are working on preparing bespoke digital product offerings to help the market continue to meet, do business and exchange ideas later this year.

Through this expansion, the CDMO will increase the total lyophilization capacity by 246% of the current capacity.

The $30 million investment will enable the site to handle large-molecule programs, with additional capacity for small molecule dosage form development.

The data generated through the partnership will help biopharma companies to develop robust manufacturing processes and minimize challenges during scale-up and commercialization.

Acryl-EZE formulations provide significant time savings and targeted drug delivery.

Data on the first clinical use of lenzilumab in patients with severe COVID-19 pneumonia suggest promising results.

Watson-Marlow's new Certa Plus sinusoidal pump provides a sustainable solution for shear sensitive, viscous pharmaceutical products.

Sterile transfer solutions without compromising operational efficiency.

Junshi Biosciences cites Lonza’s GS Xceed gene expression system as a critical enabler for the program.

Our Process Chemistry R&D laboratory at Alderley Park, Manchester is now open for business. Feel free to reach out to us for all your process development needs. Refer this link for information on our new lab.

The company is also involved in projects that aim to enable population-level screening for the current coronavirus.

Further milestone paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

The center will host a new BioReliance End-to-End Solutions GMP manufacturing facility offering CDMO services to customers in China and Asia-Pacific.

The CDMO responds to the growing demand for complex fill and finish solutions.

The agreement is aimed at helping to reduce essential drug shortages in the US

Our first in a series of monthly podcasts looks back at the key points covered in five webinars we hosted in May showcasing the pharma industry's response to the COVID-19 pandemic

In this podcast, Global Pharma Insights speaks to Stefan Schmidinger, Partner at Kemiex AG on how trading and procurement of active pharmaceutical ingredients has been affected by the global coronavirus pandemic

The company began scaling up manufacturing of REGN-COV2 at business risk earlier this year to ensure the immediate availability of the product if clinical trials prove successful.

The CRO will undertake this clinical trial at multiple sites worldwide, starting at the AZ Sint Maarten hospital in Mechelen, Belgium.

An investment of $3.6 million will cover the installation of a new production line to keep pace with continued growth in commercial-scale API manufacturing.

Companies agree that the key to tackling drug development complexity is collaboration.

The transaction will more than double Croda’s R&D capability in drug delivery.

Following on from the success of the inaugural iPitch launch in 2019, iNova Pharmaceuticals is delighted to announce the launch of a new round of iPitch challenges for 2020.

Stefano Butti, FPS Head of the Sales Group, presents the situation on the Italian market today and the news

Mr Frederic Le Pape, General Manager FPS America, presents the situation on the american market today and the news

The ability to listen and the flexibility in adapting to the needs of the customer are the strengths that over the years have rewarded FPS.

Data is the bedrock of a pharmaceutical product’s pathway to market, and the consequences of data failures can be immense. What can companies do to ensure they overcome data integrity challenges?

Two company sites - one in Canada, the other in Brazil - receive new softgel encapsulation lines to service local customer demand.

The 10-day event will feature an interactive digital marketplace for sourcing products and services, enhanced matchmaking for connecting with new and existing partners, and world-renowned speakers.

AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic.

SeaGel offers drug and dietary supplement manufacturers an animal-free and sustainable alternative to traditional soft capsules.

The global outsourcing solutions provider is also set to expand its biotech capabilities in Europe.

The prefilled pen supports more convenient self-administration for patients with chronic type 2 inflammatory diseases.

Key findings demonstrate the value of network solutions to secure and digitalize the pharmaceutical supply chain.

Luxembourg, 28 May 2020 -- CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agr...

Pionyr's "promising, novel biology" could represent a major increase in Gileads's cancer pipeline.

The CDMO will work on developing a solution and a solid oral dosage form of ViralClear's merimepodib.

As Bill Gates had correctly predicted in 2015, the greatest threat to humanity was not nuclear missiles, but microbes.

Sai Life Sciences wins Golden Peocock National Quality award 2020.

The investment will add a multi-suite operation to the Canton facility, adding up to 1000L of viral vector capacity and is expected to go online by 2023

Novel platform initially focussed on high-resolution industrial-scale processing of therapeutic mRNA.

Stevanato Group, SCHOTT, and Gerresheimer confirm their readiness to support future COVID-19 vaccine with pharmaceutical containers.

The French pharma company will also invest EUR 120 million to create a new research center at Marcy-l'Etoile dedicated to vaccines

Late-stage manufacturing services will be conducted at Catalent’s facility in Anagni, Italy in preparation for large-scale commercial supply of the vaccine

BILLERICA, Mass.,—September 18, 2019—Entegris, Inc. (Nasdaq: ENTG), a leader in specialty chemicals and advanced materials solutions, announced today it has acquired Hangzhou Anow Microfiltration Co., Ltd., a filtration company for diverse industries i...

The cost-effective capsules incorporate anti-tampering measures to ensure they comply with blinding regulations.

Supply chain executives request greater visibility and transparency, especially at the supplier and manufacturer level.

Senior leaders from across the Pharmaceutical supply chain met at CPHI Worldwide 2019 to discuss how we build a future-fit workplace that ensures everybody has the opportunity to fulfil their full potential. 

An aging population and high incidence of NCDs is continuing to drive the demand for healthcare in Thailand, where 20% of the population is aged 65 or over. Our CPHI South East Asia webinar examines the challenges associated with dosage form design for...

Much has been made of the potential of continuous platforms to supplant traditional pharmaceutical batch manufacturing and drive down API production costs. But how suitable is the technology to the precise requirements of complex pharma processing?

SoftGroup is an officially a Chestny ZNAK – accredited solution provider, delivering end-to-end traceability technology that enable companies to comply with the Russian regulations for the implementation of the serialization and aggregation solutions i...

SoftGroup’s mission to deliver an end-to-end traceability technology through innovation has been recognized for a second time with a CEE Pharmaceutical Manufacturing Excellence Award.

Webinar will help manufacturers to harness the advantages of using real-time analytics to enhance performance and reduce waste.

The deal represents the contract manufacturer's third US site.

Investment will double the site's drug substance manufacturing capacity and will expand its capabilities to include fill/finish, and enhance its current assembly, labeling and packaging services.

The collaboration will significantly increase the UK’s capacity to manufacture viral vectors vaccines as part of a national effort in response to COVID-19.

Optimizing the dosage form's efficiency reduces the amount of drug required in each patch.

The collaboration with CGT Catapult will enable Achilles to increase its GMP manufacturing capacity to supply clinical trials of its novel T cell therapy products.

The CDMO produce drug substance at large scale for commercial manufacturing with the first 2 years valued at approximately $480 million.

We are glad to announce the approval of WHO GMP certification for our manufacturing facility, VAV Lipids. Securing this GMP is yet another significant milestone for the company with meaningful validation of our quality standards as we strive to be a gl...

Poland's leading food supplements contract manufacturer has opened a new modern facility as part of its expansion plans. 

The rush to find effective vaccines against the coronavirus is only one part of the story. How is the pharmaceutical industry addressing the difficult issue of ensuring there will be enough manufacturing capacity to roll them out on a global scale?

Development partners believe orthopoxvirus vaccines have potential for scalability to supply very large markets 

Global Pharma Insights speaks to Stefan Schmidinger, Partner at Kemiex AG, on how its trade platform is bringing efficiency to a fragmented and regulated market and how traders of APIs are slowly embracing the digital revolution

The Boulder, Colorado, USA facility will increase global capacity and extend manufacturing scale.

The company will provide CDMO capabilities, capacities, and expertise to support the US government’s Warp Speed Program to pave the way for innovators to advance COVID-19 programs.

US TEC will support biopharma drug development throughout the lifecycle, helping them overcome the challenges of the container-closure system.

This innovation by Ackley Machine Corporation represents the first ever machine to offer NIR (Near-Infrared) spectroscopy alongside pharmaceutical tablet drilling and vision inspection – all in one machine.

Judges describe the CDMO's "exemplary management" as a role model for other medium-sized companies.

Vaxxas announces Merck (known as MSD outside the US and Canada) milestone and Harro Höfliger manufacturing alliance.

The licence will allow the company to perform EU clinical release for its European customers and drug developers.

The first in a quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Caroline O'Brien

Kolinpharma® expands on the European market and obtains the patent for 3 products with validation in 12 new countries.

CDMO will operate new Swiss facility due for completion in 2021 to support production of next-gen haemophilia product

SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.

Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger.

Reducing dependence on China would increase production costs for generic drug makers, analysts say

Dolatrox® is a composition for the treatment of arthropathies and osteoarthritis, as stated in the patent certificate. This composition was thus recognized as innovative and unique. Dolatrox is the 4th patent that Kolinpharma obtains in the USA.

The company's new air-conditioned facility offers temperature-controlled storage in three ranges: frozen, refrigerated, and room-temperature.

The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease.

AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets.

Evolving biopharma quality demands, the shifting regulatory landscape and the COVID-19 pandemic mean CDMOs will need to get even better at finding talent if they are to strike recruitment gold

$60 million Worcester plant should be operational by 2022 and will employ 150 people

CDMO aims to ramp up production to 8 million tubes per week via $40 million Lenexa site expansion

The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials.

ChargePoint Technology's Chief Commercial Officer says "yes" it can.

Pharma start-up will use continuous manufacturing to shore up supply chain of essential medicines

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Smart medications that can provide traceability from plant to patient.

CDMO is contracted to produce multiple clinical batches from German facility

At this year’s Pharmapack Europe, we interviewed Gregor Anderson, Managing Director at Pharmacentric Solutions on how the industry is striving for greater sustainability with regards to packaging and devices.

Voluntary licensing deals allow firms to distribute drug recently granted FDA EUA to treat patients with COVID-19 in 127 countries

CDMO says it has made "notable changes" to its supply chain processes to ensure continuing supply of medicines during COVID-19 pandemic

New application study describes the separation and characterisation of adeno associated virus serotypes by AF4.

Company's manufacturing methods and processes reviewed by an independent third-party auditor to ensure the products have the highest-quality ingredients possible.

Movement towards healthy lifestyles and preventative supplements the lasting behavioural change post COVID-19.